Literature DB >> 20378115

Impact of coronary calcium on arterial age and coronary heart disease risk estimation using the MESA arterial age calculator.

Jamalah A Munir1, Hongyan Wu, Kelly Bauer, Jody Bindeman, Carole Byrd, Patrick O'Malley, Allen J Taylor.   

Abstract

BACKGROUND: We evaluated the impact of arterial age calculation on reclassification of global coronary heart disease risk using the Framingham risk score.
METHODS: We applied CHD risk factor data from the Prospective Army Coronary Calcium Project to the MESA arterial age calculator (available at http://www.mesa-nhlbi.org). Subjects (N=1998) were studied with measured CHD risk factors and electron beam computed tomography for the identification of coronary artery calcium. Framingham risk scores (FRS), using the 10-year CHD risk model with and without arterial age, were calculated using the MESA arterial age calculator.
RESULTS: The mean FRS of the cohort (42.9 + or - 2.7 years, male gender 82%) was 4.5 + or - 3.6%. Coronary calcium was present in 394 subjects (19.7%). Application of the arterial age calculator increased mean age from 42.9 + or - 2.7 to 43.6 + or - 10.4 years (P<.001), and the mean FRS increased from 4.5 + or - 3.6 to 7.3 + or - 8.1% (P<.001). Reclassification was seen primarily among male subjects, in whom the mean age (chronological vs. arterial age) increased from 42.9 + or - 2.7 to 44.2 + or - 11.0 (P<.001) and the prevalence of high CHD risk increased from 0.6% (10 of 1639) to 10% (165 of 1639; P<.001).
CONCLUSION: Among healthy individuals ages 40-50, application of the MESA arterial age calculator reclassifies 1 in 10 men from low to intermediate risk and 1 in 15 men from low to high risk. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20378115     DOI: 10.1016/j.atherosclerosis.2010.03.016

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  1 in total

Review 1.  A low-dose combination of fluvastatin and valsartan: a new "drug" and a new approach for decreasing the arterial age.

Authors:  Miodrag Janić; Mojca Lunder; Mišo Šabovič
Journal:  Biomed Res Int       Date:  2015-03-03       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.